Y-27632
目录号:S6390 Purity: 99.92%
Y-27632是一种选择性ROCK1和ROCK2抑制剂,无细胞试验中Ki分别为140 nM和300nM,比对其他激酶包括PKC,cAMP依赖性蛋白激酶,MLCK和PAK的作用强200多倍。
CAS: 146986-50-7
客户使用Selleck的Y-27632发表文献432篇
- Nature, 2024 10.1038/s41586-024-07260-z
- Science, 2024 383(6687):eadi7342
- Cell Stem Cell, 2024 S1934-5909(24)00094-8
- Nat Cell Biol, 2024 26(11):1878-1891
- Nature, 2023 622(7982):359-366
- Nature, 2023 616(7957):495-503
- Nature, 2023 617(7959):139-146
- Cell Discov, 2023 9(1):53
- Nat Immunol, 2023 24(8):1382-1390
- Adv Mater, 2023 35(52):e2305911
- Adv Mater, 2023 e2300305.
- Nat Cell Biol, 2023 25(8):1223-1234
- J Thorac Oncol, 2023 18(10):1362-1385
- Nature, 2022 612(7939):347-353
- Nature, 2022 612(7940):555-563
- Nat Methods, 2022 10.1038/s41592-022-01643-8
- Cell Res, 2022 10.1038/s41422-022-00614-0
- Cell Discov, 2022 8(1):118
- Cell Metab, 2022 S1550-4131-2200411-9
- Protein Cell, 2022 10.1007/s13238-022-00906-6
- Nature, 2021 600(7888):285-289
- Eur Respir J, 2021 2100908
- Nat Commun, 2024 15(1):4771
- Nat Commun, 2024 15(1):4598
- Nat Commun, 2024 15(1):2207
- Nat Commun, 2024 15(1):4096
- Nat Commun, 2024 15(1):2938
- J Clin Invest, 2024 134(17)e175217
- Adv Sci (Weinh), 2024 11(42):e2406653
- Mol Neurodegener, 2024 19(1):31
- Adv Sci (Weinh), 2024 11(3):e2304303
- Nucleic Acids Res, 2024 gkae740
- Cell Rep Med, 2024 5(2):101396
- Allergy, 2024 10.1111/all.16416
- Gut Microbes, 2024 16(1):2379566
- J Exp Clin Cancer Res, 2024 43(1):299
- J Exp Clin Cancer Res, 2024 43(1):88
- EBioMedicine, 2024 110:105476
- J Biomed Sci, 2024 31(1):68
- J Adv Res, 2024 S2090-1232(24)00413-2
- J Nanobiotechnology, 2024 22(1):132
- PLoS Biol, 2024 22(5):e3002621
- Am J Hum Genet, 2024 111(4):714-728
- Acta Biomater, 2024 S1742-7061(24)00036-9
- Cell Rep, 2024 43(12):115065
- Cell Rep, 2024 43(10):114814
- Cell Prolif, 2024 e13762.
- Transl Res, 2024 273:58-77
- Elife, 2024 13RP93405
- Stem Cell Res Ther, 2024 15(1):310
- Biomed Pharmacother, 2024 177:117038
- Stem Cell Res Ther, 2024 15(1):374
- Stem Cell Res Ther, 2024 15(1):236
- Stem Cell Res Ther, 2024 15(1):48
- Stem Cell Res Ther, 2024 15(1):26
- Front Immunol, 2024 15:1382661
- Cell Mol Gastroenterol Hepatol, 2024 18(3):101358
- Cell Death Discov, 2024 10(1):474
- Antioxidants (Basel), 2024 13(12)1482
- Ecotoxicol Environ Saf, 2024 285:117051
- Neural Regen Res, 2024 19(2):458-464
- Lab Chip, 2024 24(8):2208-2223
- Cells, 2024 13(15)1260
- Commun Biol, 2024 7(1):1460
- Commun Biol, 2024 7(1):1223
- Commun Biol, 2024 7(1):736
- Stem Cell Reports, 2024 S2213-6711(24)00108-5
- iScience, 2024 27(6):109967
- Cancer Cell Int, 2024 24(1):131
- Mol Ther Oncol, 2024 32(1):200784
- Mol Ther Oncol, 2024 32(2):200807
- Int J Mol Sci, 2024 25(14)7971
- Int J Mol Sci, 2024 25(3):1444.
- Int J Mol Sci, 2024 25(1)576
- Biomolecules, 2024 14(9)1126
- Front Cell Dev Biol, 2024 12:1413882
- Burns Trauma, 2024 12:tkae045
- Aging (Albany NY), 2024 16(8):6673-6693
- Hepatol Commun, 2024 8(2)e0378
- Transl Oncol, 2024 42:101900
- J Biomed Mater Res A, 2024 10.1002/jbm.a.37737
- Zool Res, 2024 45(2):233-241
- FASEB J, 2024 38(20):e70117
- Neoplasia, 2024 53:101005
- Neoplasia, 2024 51:100984
- Front Oncol, 2024 14:1361603
- Viruses, 2024 16(4)552
- J Dermatol Sci, 2024 S0923-1811(24)00152-X
- Sci Rep, 2024 14(1):4505
- Sci Rep, 2024 14(1):2243
- Toxicology, 2024 508:153930
- Cell Physiol Biochem, 2024 58(5):538-547
- Regen Ther, 2024 25:229-237
- Biology (Basel), 2024 13(9)684
- Bone, 2024 181:117044
- PLoS One, 2024 19(5):e0303260
- Dig Dis Sci, 2024 10.1007/s10620-024-08570-y
- J Oral Biosci, 2024 S1349-0079(24)00195-6
- Biol Open, 2024 13(3)bio060323
- Sci Adv, 2024 10(47):eadq9793
- Sci Adv, 2024 10(9):eadh7748
- Sci Adv, 2024 10(11):eadk0785
- Sci Adv, 2024 10(5):eadk1034
- Stem Cell Res, 2024 82:103627
- Stem Cell Res, 2024 81:103599
- Stem Cell Res, 2024 82:103626
- Stem Cell Res, 2024 82:103641
- Stem Cell Res, 2024 81:103569
- Stem Cell Res, 2024 81:103615
- Stem Cell Res, 2024 81:103580
- Stem Cell Res, 2024 81:103579
- Stem Cell Res, 2024 82:103632
- Stem Cell Res, 2024 80:103526
- Stem Cell Res, 2024 80:103530
- Stem Cell Res, 2024 80:103497
- Stem Cell Res, 2024 78:103453
- Stem Cell Res, 2024 78:103457
- Stem Cell Res, 2024 80:103529
- Stem Cell Res, 2024 77:103395
- Stem Cell Res, 2024 77:103433
- Stem Cell Res, 2024 77:103420
- Stem Cell Res, 2024 74:103273
- Stem Cell Res, 2024 75:103304
- Stem Cell Res, 2024 74:103281
- Bio Protoc, 2024 14(22):e5116
- Zhejiang Da Xue Xue Bao Yi Xue Ban, 2024 53(4):498-508
- Nat Cardiovasc Res, 2024 3(10):1217-1235
- bioRxiv, 2024 2024.07.12.603155
- bioRxiv, 2024 2024.06.29.601287
- PNAS Nexus, 2024 3(5):pgae179
- bioRxiv, 2024 2024.05.13.593960
- bioRxiv, 2024 2024.01.25.577277
- FEMS Microbes, 2024 5:xtae014
- bioRxiv, 2024 2024.04.10.588874
- Nat Phys, 2023 19(4):586-596
- Bioact Mater, 2023 22:482-490
- Bioact Mater, 2023 20:286-305
- Nat Commun, 2023 10.1038/s41467-023-42560-4
- Nat Commun, 2023 14(1):5176
- Nat Commun, 2023 14(1):2902
- Mol Cell, 2023 83(17):3095-3107.e9
- Nucleic Acids Res, 2023 51(8):3806-3819
- Cell Rep Med, 2023 10.1016/j.xcrm.2023.101244
- Cell Rep Med, 2023 4(4):101007
- Cell Rep Med, 2023 4(4):101002
- Dev Cell, 2023 58(7):535-549.e5
- J Exp Clin Cancer Res, 2023 42(1):260
- J Exp Clin Cancer Res, 2023 42(1):281
- Cancer Res, 2023 83(16):2716-2732
- Research -Wash D C), 2023 6:0224
- Adv Healthc Mater, 2023 12(19):e2202422
- J Neuroinflammation, 2023 20(1):51
- Biofabrication, 2023 15(4).
- Cell Rep, 2023 42(10):113160
- Cell Rep, 2023 42(6):112566
- Mol Ther Nucleic Acids, 2023 32:522-535
- Cell Rep, 2023 42(5):112438
- Mol Ther Nucleic Acids, 2023 31:494-511
- Cell Rep, 2023 42(8):112791
- Cell Prolif, 2023 56(5):e13469
- JCI Insight, 2023 8(13)e159141
- Oncogene, 2023 10.1038/s41388-023-02676-9 10.3322/caac.21660 10.1001/jama.2021.6021 10.1038/nrdp.2015.65 10.1038/s41575-019-0189-8 10.1038/nature11252 10.1038/s41392
- NPJ Precis Oncol, 2023 7(1):127
- Cell Biosci, 2023 13(1):201
- Stem Cell Res Ther, 2023 14(1):92
- Front Immunol, 2023 14:1258074
- J Pathol, 2023 10.1002/path.6065
- Cell Mol Gastroenterol Hepatol, 2023 16(3):451-472
- Acta Neuropathol Commun, 2023 11(1):150
- Antioxidants (Basel), 2023 12(8)1585
- Cell Prolif, 2023 e13544.
- Cells, 2023 12(8)1174
- Cells, 2023 12(3)373
- Cells, 2023 12(2)339
- iScience, 2023 26(2):105939
- Int J Mol Sci, 2023 24(5)4909
- Int J Mol Sci, 2023 24(11)9548
- Int J Mol Sci, 2023 24(4)3867
- Int J Mol Sci, 2023 24(1)768
- Front Cell Dev Biol, 2023 29(1):132
- Aging (Albany NY), 2023 15(18):9238-9249
- Cancers (Basel), 2023 15(6)1729
- Am J Physiol Lung Cell Mol Physiol, 2023 324(6):L771-L782
- Stem Cell Rev Rep, 2023 19(4):1067-1081
- Front Oncol, 2023 13:1118268
- Sci Rep, 2023 13(1):18573
- Sci Rep, 2023 13(1):22118
- Sci Rep, 2023 13(1):12884
- Sci Rep, 2023 10.1038/s41598-023-45585-3
- Development, 2023 150(14)dev201386
- Life Sci Alliance, 2023 6(11)e202302058
- Life Sci Alliance, 2023 6(11)e202302121
- Dis Colon Rectum, 2023 66(5):733-743
- Front Cardiovasc Med, 2023 10:1162731
- Genes (Basel), 2023 14(9)1781
- Mol Biol Cell, 2023 34(8):ar79
- Technol Cancer Res Treat, 2023 22:15330338221146024
- J Cardiovasc Dev Dis, 2023 10(3)110
- Sci Adv, 2023 9(35):eadg9245
- Sci Adv, 2023 9(29):eadf7195
- Stem Cell Res, 2023 72:103213
- Stem Cell Res, 2023 71:103156
- Stem Cell Res, 2023 66:103003
- Stem Cell Res, 2023 71:103177
- Stem Cell Res, 2023 71:103155
- Stem Cell Res, 2023 10.1016/j.scr.2023.103202
- Stem Cell Res, 2023 72:103218
- Stem Cell Res, 2023 66:103013
- Stem Cell Res, 2023 67:103019
- Nat Cardiovasc Res, 2023 2(2):159-173
- Res Sq, 2023 rs.3.rs-3372987
- bioRxiv, 2023 2023.11.06.565933
- bioRxiv, 2023 2023.05.22.541773
- bioRxiv, 2023 2023.06.22.544406
- Cell Regen, 2023 12(1):27
- Res Sq, 2023 rs.3.rs-2674668
- bioRxiv, 2023 2023.01.24.525458
- bioRxiv, 2023 2023.09.13.556416
- Cell Regen, 2023 12(1):30
- Neuropsychopharmacol Rep, 2023 10.1002/npr2.12361
- JBMR Plus, 2023 7(2):e10711
- Bioact Mater, 2022 16:346-358
- Sci Transl Med, 2022 14(672):eade1633
- Sci Transl Med, 2022 14-661:eabo5987
- Nat Commun, 2022 13(1):3135
- Nat Commun, 2022 13(1):4444
- Nat Commun, 2022 13(1):2070
- Nat Commun, 2022 13(1):3147
- Nat Commun, 2022 13(1):3022
- Nat Commun, 2022 13(1):2756
- Nat Commun, 2022 13(1):791
- J Extracell Vesicles, 2022 11(11):e12280
- Mol Cell, 2022 S1097-2765(22)00442-7
- Adv Sci (Weinh), 2022 9(27):e2200475
- Adv Sci (Weinh), 2022 e2106075
- Adv Sci (Weinh), 2022 e2104299
- Brain, 2022 awac278
- Biomaterials, 2022 291:121883
- Small, 2022 18(31):e2201167
- Bone Res, 2022 10(1):20
- Allergy, 2022 10.1111/all.15457
- Genome Biol, 2022 23(1):106
- Cancer Res, 2022 82(24):4604-4623
- Proc Natl Acad Sci U S A, 2022 119(20):e2115709119
- EMBO Mol Med, 2022 14(12):e15795
- EBioMedicine, 2022 85:104274
- Adv Healthc Mater, 2022 e2201846
- Adv Healthc Mater, 2022 e2201984
- Adv Healthc Mater, 2022 e2102345
- Angiogenesis, 2022 10.1007/s10456-022-09846-5
- Cell Death Dis, 2022 13(10):881
- Biofabrication, 2022 2022-04-14
- Cell Death Dis, 2022 13(6):559
- Food Chem, 2022 396:133657
- J Tissue Eng, 2022 13:20417314221143240
- Cell Mol Life Sci, 2022 79(10):526
- J Crohns Colitis, 2022 jjac101
- JCI Insight, 2022 7(7)e155640
- Elife, 2022 11e71591
- Elife, 2022 11e82658
- Stem Cell Res Ther, 2022 13(1):412
- Front Immunol, 2022 13:1005426
- Front Immunol, 2022 13:1018047
- Cell Mol Gastroenterol Hepatol, 2022 13(5):1554-1589
- Cell Mol Gastroenterol Hepatol, 2022 S2352-345X(22)00074-1
- Cell Death Discov, 2022 8(1):50
- mBio, 2022 13(6):e0230822.
- Cells, 2022 11(12)1955
- Cells, 2022 11(24)4013
- Cells, 2022 11(21)3377
- Stem Cell Reports, 2022 17(6):1493-1506
- Commun Biol, 2022 5(1):52
- Commun Biol, 2022 5(1):1246
- Stem Cell Reports, 2022 17(12):2674-2689
- Stem Cell Reports, 2022 17(7):1743-1756
- Stem Cell Reports, 2022 S2213-6711(22)00202-8
- iScience, 2022 25-10:104971
- Biochem Pharmacol, 2022 201:115077
- iScience, 2022 25(1):103645
- Front Bioeng Biotechnol, 2022 10:939774
- Front Bioeng Biotechnol, 2022 10:819148
- Int J Mol Sci, 2022 23-2012657
- Front Pharmacol, 2022 13:807440
- Pharmaceutics, 2022 14(2)400
- J Cell Mol Med, 2022 26(19):4949-4958
- NPJ Genom Med, 2022 7(1):28
- Cancers (Basel), 2022 14(12)3015
- Front Endocrinol (Lausanne), 2022 13:913979
- Cancers (Basel), 2022 14(21)5215
- Cancers (Basel), 2022 14(17)4196
- Cancers (Basel), 2022 14(10)2511
- Cancers (Basel), 2022 14(7)1630
- Front Mol Biosci, 2022 9:905468
- Front Mol Biosci, 2022 9:714008
- J Pers Med, 2022 12(2)258
- Am J Physiol Lung Cell Mol Physiol, 2022 322(1):L149-L161
- Front Mol Neurosci, 2022 15:889922
- FASEB J, 2022 36(10):e22540
- Stem Cell Rev Rep, 2022 18(4):1434-1443
- J Biol Chem, 2022 S0021-9258-2201013-4
- J Biol Chem, 2022 S0021-9258(22)00494-X
- Mol Ther Methods Clin Dev, 2022 24:332-341
- Carcinogenesis, 2022 bgac014
- Sci Rep, 2022 12(1):17409
- Sci Rep, 2022 12(1):9143
- J Proteome Res, 2022 21(9):2211-2223
- Hum Cell, 2022 35(6):1993-2001
- Hum Cell, 2022 35(5):1621-1629
- Hum Cell, 2022 35(4):1279-1289
- Hum Cell, 2022 35(4):1290-1297
- Hum Cell, 2022 35(1):384-391
- Hum Cell, 2022 10.1007/s13577-022-00701-9
- Hum Cell, 2022 10.1007/s13577-022-00689-2
- Hum Cell, 2022 10.1007/s13577-022-00671-y
- J Immunol Res, 2022 2022:3423692
- PLoS One, 2022 17(11):e0269122
- PLoS One, 2022 17(5):e0268860
- Biol Reprod, 2022 107(1):237-249
- Cell Tissue Res, 2022 10.1007/s00441-022-03576-2
- World J Surg Oncol, 2022 20(1):347
- Infect Immun, 2022 90(7):e0066321
- DNA Cell Biol, 2022 41(4):447-455
- Biochem Biophys Res Commun, 2022 606:42-48
- Exp Ther Med, 2022 23(5):355
- Mol Genet Metab Rep, 2022 31:100863
- Sci Adv, 2022 8(49):eabp9683
- Sci Adv, 2022 8(31):eabn3986
- Sci Adv, 2022 8(19):eabn1229
- Stem Cell Res, 2022 64:102898
- Stem Cell Res, 2022 65:102941
- Stem Cell Res, 2022 65:102969
- Stem Cell Res, 2022 66:102987
- Stem Cell Res, 2022 62:102809
- Stem Cell Res, 2022 63:102855
- Stem Cell Res, 2022 64:102883
- Stem Cell Res, 2022 64:102893
- Stem Cell Res, 2022 62:102813
- Stem Cell Res, 2022 61:102774
- Stem Cell Res, 2022 62:102795
- Stem Cell Res, 2022 60:102720
- Stem Cell Res, 2022 60:102726
- Stem Cell Res, 2022 60:102725
- Stem Cell Res, 2022 60:102724
- Stem Cell Res, 2022 61:102753
- Stem Cell Res, 2022 61:102754
- Stem Cell Res, 2022 60:102685
- Stem Cell Res, 2022 60:102693
- Stem Cell Res, 2022 59:102657
- Cell Rep Methods, 2022 2(9):100290
- STAR Protoc, 2022 3(3):101638
- Immunohorizons, 2022 6(7):416-429
- Front Genome Ed, 2022 4:843885
- Cell Regen, 2022 11(1):7
- Nat Commun, 2021 12(1):5826
- Nat Commun, 2021 12(1):5315
- Nat Commun, 2021 12(1):4580
- Adv Sci (Weinh), 2021 e2103495
- Genome Med, 2021 13(1):142
- Genome Med, 2021 13(1):116
- Cancer Res, 2021 canres.1443.2021
- EBioMedicine, 2021 74:103713
- Acta Biomater, 2021 S1742-7061(21)00586-9
- Cell Death Dis, 2021 12(12):1119
- Cell Rep, 2021 35(13):109291
- Cell Rep, 2021 37(9):110060
- Cell Commun Signal, 2021 19(1):95
- Stem Cell Res Ther, 2021 12(1):553
- Stem Cell Res Ther, 2021 12(1):555
- Anal Chem, 2021 10.1021/acs.analchem.1c04641
- Front Immunol, 2021 12:704172
- Front Immunol, 2021 12:697071
- Cell Mol Gastroenterol Hepatol, 2021 12(3):873-889
- Cell Mol Gastroenterol Hepatol, 2021 13(2):517-540
- Cell Mol Gastroenterol Hepatol, 2021 S2352-345X(21)00224-1
- Ocul Surf, 2021 22:213-223
- Cells, 2021 10(4)876
- Cells, 2021 10(10)2576
- Cells, 2021 10(9)2214
- Cells, 2021 10(10)2574
- Cells, 2021 10(9)2424
- ACS Biomater Sci Eng, 2021 7(9):4602-4613
- Front Bioeng Biotechnol, 2021 9:738081
- Int J Mol Sci, 2021 22(19)10457
- Int J Mol Sci, 2021 22(15)8224
- Biomolecules, 2021 11(10)1479
- Front Cell Dev Biol, 2021 9:820105
- J Virol, 2021 JVI0106321
- J Mol Cell Cardiol, 2021 162:144-157
- J Pers Med, 2021 11(11)1075
- Stem Cell Rev Rep, 2021 10.1007/s12015-021-10232-9
- FASEB J, 2021 35(9):e21799
- Biomedicines, 2021 9(9)1230
- Sci Rep, 2021 11(1):22911
- Molecules, 2021 26(16)4747
- Sci Rep, 2021 11(1):17100
- Am J Physiol Gastrointest Liver Physiol, 2021 10.1152/ajpgi.00165.2021
- Hum Cell, 2021 10.1007/s13577-021-00643-8
- Hum Cell, 2021 10.1007/s13577-021-00639-4
- Hum Cell, 2021 10.1007/s13577-021-00612-1
- Cell Biol Int, 2021 10.1002/cbin.11715
- Hum Mol Genet, 2021 ddab299
- Cell Transplant, 2021 30:9636897211017830
- J Mass Spectrom Adv Clin Lab, 2021 20:11-24
- BMC Anesthesiol, 2021 21(1):212
- Sci Adv, 2021 7(33)eabf4416
- Stem Cell Res, 2021 57:102574
- Stem Cell Res, 2021 59:102638
- Stem Cell Res, 2021 57:102605
- Stem Cell Res, 2021 57:102610
- Stem Cell Res, 2021 56:102512
- Stem Cell Res, 2021 56:102543
- Stem Cell Res, 2021 56:102532
- Stem Cell Res, 2021 55:102505
- Stem Cell Res, 2021 55:102455
- Cell Regen, 2021 10(1):30
- Methods Mol Biol, 2021 2319:51-60
- Theranostics, 2020 10(24):11215-11229
- Clin Transl Med, 2020 10(8):e247.
- Front Cell Dev Biol, 2020 8:432
- Clin Cancer Res, 2019 25(20):6243-6259
- Biomater Sci, 2019 7(12):5388-5403
- RNA, 2019 25(9):1118-1129
- ACS Biomater Sci Eng, 2018 4(5):1908-1915
- J Mol Med (Berl), 2018 96(2):119-133
- Sci Signal, 2016 9(450):rs12
- Sci Rep, 2016 6:32669
- Neurochem Res, 2016 41(9):2457-69
- Haematologica, 2015 100(2):157-66
- J Biol Chem, 2015 290(20):12463-73
- Mol Biol Cell, 2015 26(11):1995-2004
- Archives of Oral Biology, 2015 875-882
- ProQuest, 2015
化学信息&溶解度
分子量 | 247.34 |
分子式 | C14H21N3O |
CAS号 | 146986-50-7 |
Smiles | CC(N)C1CCC(CC1)C(=O)NC2=CC=NC=C2 |
储存条件(自收到货起) | 3年 -20°C 粉状 |
建议分装储备液,避免反复冻融! |
|
体外溶解度 | 批次: |
DMSO : 49 mg/mL ( 198.1 mM; DMSO吸湿会降低化合物溶解度,请使用新开封DMSO) Ethanol : 49 mg/mL Water : Insoluble DMSO : 49 mg/mL ( 198.1 mM; DMSO吸湿会降低化合物溶解度,请使用新开封DMSO) Ethanol : 49 mg/mL Water : Insoluble |
体内溶解度 | 批次: |
现配现用,请按从左到右的顺序依次添加,澄清后再加入下一溶剂 | |
5%DMSO
40%PEG300
5%Tween80
50%ddH2O
浓度:2.5mg/ml
(10.11mM)
操作示例:以 1 mL 工作液为例,取50μL50mg/ml的澄清DMSO储备液加到 400μL PEG300中,混合均匀使其澄清;向上述体系中加入50μLTween80,混合均匀使其澄清;然后继续加入500μL ddH2O定容至 1 mL。工作液请现配现用!
|
摩尔浓度计算器
质量(g)= 浓度(mol/L)* 体积(L)* 分子量(g/mol)
动物体内配方计算器(澄清溶液)
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系Selleck为您提供正确的澄清溶液配方)
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,注:如该浓度超过该批次药物DMSO溶解度,请先联系Selleck);
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入 μL Tween 80,混匀澄清后加入 μL ddH2O,混匀澄清。
体内配方配制方法:取 μL DMSO母液,加入 μL Corn oil,混匀澄清。
注意:
1. 首先保证母液是澄清的;
2.一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。